Evidence map›Paper›PMID 26139534›Full record

ArticleThe EMBO journal2015

Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion.

Marilyn Giordano, Coralie Henin, Julien Maurizio, Claire Imbratta, Pierre Bourdely, Michel Buferne, Lukas Baitsch, Laurent Vanhille, Michael H Sieweke, Daniel E Speiser and 3 more

Abstract read
In one paragraph

Article in The EMBO journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 128 citations in OpenAlex.

  1. Trial
  2. Regulators of CD8Nature reviews. Immunology · 2026
    Review
  3. Tumor-driven stabilization of CD8Frontiers in immunology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Myeloid cells meet CD8Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2024
    Article
  12. Article
  13. NaCl enhances CD8Nature immunology · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. TIM-3Science immunology · 2024
    Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Marilyn GiordanoCentre d'Immunologie de Marseille-Luminy (CIML), UM2 Aix-Marseille Université, Marseille Cedex 9, France INSERM U1104, Marseille, France CNRS UMR7280, Marseille, France.
Coralie HeninCentre d'Immunologie de Marseille-Luminy (CIML), UM2 Aix-Marseille Université, Marseille Cedex 9, France INSERM U1104, Marseille, France CNRS UMR7280, Marseille, France.
Julien MaurizioCentre d'Immunologie de Marseille-Luminy (CIML), UM2 Aix-Marseille Université, Marseille Cedex 9, France INSERM U1104, Marseille, France CNRS UMR7280, Marseille, France.
Claire ImbrattaClinical Tumor Biology & Immunotherapy Group, Department of Oncology and Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland.
Pierre BourdelyCentre d'Immunologie de Marseille-Luminy (CIML), UM2 Aix-Marseille Université, Marseille Cedex 9, France INSERM U1104, Marseille, France CNRS UMR7280, Marseille, France.
Michel BuferneCentre d'Immunologie de Marseille-Luminy (CIML), UM2 Aix-Marseille Université, Marseille Cedex 9, France INSERM U1104, Marseille, France CNRS UMR7280, Marseille, France.
Lukas BaitschClinical Tumor Biology & Immunotherapy Group, Department of Oncology and Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland.
Laurent VanhilleCentre d'Immunologie de Marseille-Luminy (CIML), UM2 Aix-Marseille Université, Marseille Cedex 9, France INSERM U1104, Marseille, France CNRS UMR7280, Marseille, France.
Michael H SiewekeCentre d'Immunologie de Marseille-Luminy (CIML), UM2 Aix-Marseille Université, Marseille Cedex 9, France INSERM U1104, Marseille, France CNRS UMR7280, Marseille, France Max-Delbrück-Centrum für Molekulare Medizin (MDC), Berlin, Germany.
Daniel E SpeiserClinical Tumor Biology & Immunotherapy Group, Department of Oncology and Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland.
Nathalie Auphan-AnezinCentre d'Immunologie de Marseille-Luminy (CIML), UM2 Aix-Marseille Université, Marseille Cedex 9, France INSERM U1104, Marseille, France CNRS UMR7280, Marseille, France.
Anne-Marie Schmitt-VerhulstCentre d'Immunologie de Marseille-Luminy (CIML), UM2 Aix-Marseille Université, Marseille Cedex 9, France INSERM U1104, Marseille, France CNRS UMR7280, Marseille, France.
Grégory VerdeilCentre d'Immunologie de Marseille-Luminy (CIML), UM2 Aix-Marseille Université, Marseille Cedex 9, France INSERM U1104, Marseille, France CNRS UMR7280, Marseille, France gregory.verdeil@unil.ch.
Aix-Marseille Université · FRUniversity of Lausanne · CHCentre d’Immunologie de Marseille-Luminy · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T cells infiltrating neoplasms express surface molecules typical of chronically virus-stimulated T cells, often termed "exhausted" T cells. We compared the transcriptome of "exhausted" CD8 T cells infiltrating autochthonous melanomas to those of naïve and acutely stimulated CD8 T cells. Despite strong similarities between transcriptional signatures of tumor- and virus-induced exhausted CD8 T cells, notable differences appeared. Among transcriptional regulators, Nr4a2 and Maf were highly overexpressed in tumor-exhausted T cells and significantly upregulated in CD8 T cells from human melanoma metastases. Transduction of murine tumor-specific CD8 T cells to express Maf partially reproduced the transcriptional program associated with tumor-induced exhaustion. Upon adoptive transfer, the transduced cells showed normal homeostasis but failed to accumulate in tumor-bearing hosts and developed defective anti-tumor effector responses. We further identified TGFβ and IL-6 as main inducers of Maf expression in CD8 T cells and showed that Maf-deleted tumor-specific CD8 T cells were much more potent to restrain tumor growth in vivo. Therefore, the melanoma microenvironment contributes to skewing of CD8 T cell differentiation programs, in part by TGFβ/IL-6-mediated induction of Maf.

Indexed as

AnimalsCD8-Positive T-LymphocytesCell DifferentiationDNA PrimersFlow CytometryGene Expression ProfilingHomeodomain ProteinsInterleukin-6LuciferasesMelanomaMiceMice, TransgenicProto-Oncogene Proteins c-mafReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionTransforming Growth Factor betaDNA PrimersHomeodomain ProteinsInterleukin-6LuciferasesMAF protein, humanProto-Oncogene Proteins c-mafRAG-1 proteinTransforming Growth Factor betaMafmelanomaT‐cell exhaustionTGFβ

Identifiers

PMID26139534
PMCPMC4551351
OpenAlexW2737737799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.